Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Protein Degradation Systems: Controlling Protein Stability Using E3 Ubiquitin Ligases in Eukaryotic Species. | Cells | 2024 | 38247866 | PubTator, text mining | PubMed |
| The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. | Chem Sci | 2024 | 38239681 | PubTator, text mining | PubMed |
| An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors. | J Biol Eng | 2024 | 38229076 | PubTator, text mining | PubMed |
| Eternal Youth: A Comprehensive Exploration of Gene, Cellular, and Pharmacological Anti-Aging Strategies. | Int J Mol Sci | 2024 | 38203812 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes. | J Extracell Vesicles | 2024 | 38191764 | PubTator, text mining | PubMed |
| The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding. | Commun Biol | 2024 | 38182755 | PubTator, text mining | PubMed |
| Direct translation of incoming retroviral genomes. | Nat Commun | 2024 | 38182622 | PubTator, text mining | PubMed |
| Induced protein degradation for therapeutics: past, present, and future. | J Clin Invest | 2024 | 38165043 | PubTator, text mining | PubMed |
| RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding. | J Exp Clin Cancer Res | 2024 | 38163890 | PubTator, text mining | PubMed |
| C/EBPβ-induced lymphoid-to-myeloid transdifferentiation emulates granulocyte-monocyte progenitor biology. | Stem Cell Reports | 2024 | 38157851 | PubTator, text mining | PubMed |
| Dissecting Ubiquitylation and DNA Damage Response Pathways in the Yeast Saccharomyces cerevisiae Using a Proteome-Wide Approach. | Mol Cell Proteomics | 2024 | 38101750 | PubTator, text mining | PubMed |
| Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506-Binding Protein 51 (FKBP51). | Angew Chem Int Ed Engl | 2024 | 37942685 | PubTator, text mining | PubMed |
| Generation of Bioactivity-Tailored FK506/FK520 Analogs by CRISPR Editing in Streptomyces tsukubaensis. | Chemistry | 2024 | 37855054 | PubTator, text mining | PubMed |
| Recent advances in targeted protein degraders as potential therapeutic agents. | Mol Divers | 2024 | 36790583 | PubTator, text mining | PubMed |
| Modeling genetic mosaicism of the mammalian target of rapamycin pathway in the cerebral cortex. | Front Mamm Sci | 2023 | 42094747 | PubTator, text mining | PubMed |
| Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. | J Soc Cardiovasc Angiogr Interv | 2023 | 39130710 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated protein delivery to the liver. | J Extracell Biol | 2023 | 38938374 | PubTator, text mining | PubMed |
| The RRE-Rev Module Has No Effect on the Packaging Efficiency of Cas9 and Gag Proteins into NanoMEDIC Virus-like Particles. | Dokl Biol Sci | 2023 | 38472686 | PubTator, text mining | PubMed |
| Proteome-Wide Fragment-Based Ligand and Target Discovery. | Isr J Chem | 2023 | 38213795 | PubTator, text mining | PubMed |
| mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age. | Diagnostics (Basel) | 2023 | 38201347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=5